Literature DB >> 22328506

Neuregulin-1 potentiates agrin-induced acetylcholine receptor clustering through muscle-specific kinase phosphorylation.

Shyuan T Ngo1, Rebecca N Cole, Nana Sunn, William D Phillips, Peter G Noakes.   

Abstract

At neuromuscular synapses, neural agrin (n-agrin) stabilizes embryonic postsynaptic acetylcholine receptor (AChR) clusters by signalling through the muscle-specific kinase (MuSK) complex. Live imaging of cultured myotubes showed that the formation and disassembly of primitive AChR clusters is a dynamic and reversible process favoured by n-agrin, and possibly other synaptic signals. Neuregulin-1 is a growth factor that can act through muscle ErbB receptor kinases to enhance synaptic gene transcription. Recent studies suggest that neuregulin-1-ErbB signalling can modulate n-agrin-induced AChR clustering independently of its effects on transcription. Here we report that neuregulin-1 increased the size of developing AChR clusters when injected into muscles of embryonic mice. We investigated this phenomenon using cultured myotubes, and found that in the ongoing presence of n-agrin, neuregulin-1 potentiates AChR clustering by increasing the tyrosine phosphorylation of MuSK. This potentiation could be blocked by inhibiting Shp2, a postsynaptic tyrosine phosphatase known to modulate the activity of MuSK. Our results provide new evidence that neuregulin-1 modulates the signaling activity of MuSK and hence might function as a second-order regulator of postsynaptic AChR clustering at the neuromuscular synapse. Thus two classic synaptic signalling systems (neuregulin-1 and n-agrin) converge upon MuSK to regulate postsynaptic differentiation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22328506     DOI: 10.1242/jcs.095109

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  23 in total

Review 1.  Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis.

Authors:  Jeffrey T Guptill; Madhu Soni; Matthew N Meriggioli
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

2.  The ER structural protein Rtn4A stabilizes and enhances signaling through the receptor tyrosine kinase ErbB3.

Authors:  Jason Hatakeyama; Jessica H Wald; Hanine Rafidi; Antonio Cuevas; Colleen Sweeney; Kermit L Carraway
Journal:  Sci Signal       Date:  2016-06-28       Impact factor: 8.192

3.  Specific effects of neuregulin-1β on the communication between DRG neurons and skeletal muscle cells in vitro.

Authors:  Menglin Cong; Jianmin Li; Yuan Qiao; Rui Jing; Hao Li; Zhenzhong Li
Journal:  J Muscle Res Cell Motil       Date:  2018-09-12       Impact factor: 2.698

4.  [Sepsis impairs aggregation of nicotinic acetylcholine receptors on murine skeletal muscle cell membranes by inhibiting AKT/GSK3β phosphorylation].

Authors:  Tianmei Li; Li Liu; Xiaobin Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-11-30

5.  Biomechanical strain vehicles for fibroblast-directed skeletal myoblast differentiation and myotube functionality in a novel coculture.

Authors:  Michael R Hicks; Thanh V Cao; Paul R Standley
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-15       Impact factor: 4.249

6.  Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction.

Authors:  Nazanin Ghazanfari; Marco Morsch; Stephen W Reddel; Simon X Liang; William D Phillips
Journal:  J Physiol       Date:  2014-05-23       Impact factor: 5.182

7.  Neuregulin1 fine-tunes pre-, post-, and perisynaptic neuromuscular junction development.

Authors:  Jiajing Wang; Fei Song; Jeffrey A Loeb
Journal:  Dev Dyn       Date:  2017-03-20       Impact factor: 3.780

8.  Rapid transient isoform-specific neuregulin1 transcription in motor neurons is regulated by neurotrophic factors and axon-target interactions.

Authors:  Jiajing Wang; Abdelkrim Hmadcha; Vaagn Zakarian; Fei Song; Jeffrey A Loeb
Journal:  Mol Cell Neurosci       Date:  2015-04-22       Impact factor: 4.314

9.  Stem cell-derived tissue-engineered constructs for hemilaryngeal reconstruction.

Authors:  Stacey L Halum; Khadijeh Bijangi-Vishehsaraei; Hongji Zhang; John Sowinski; Marco C Bottino
Journal:  Ann Otol Rhinol Laryngol       Date:  2014-02       Impact factor: 1.547

10.  MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.

Authors:  Maartje G Huijbers; Wei Zhang; Rinse Klooster; Erik H Niks; Matthew B Friese; Kirsten R Straasheijm; Peter E Thijssen; Hans Vrolijk; Jaap J Plomp; Pauline Vogels; Mario Losen; Silvère M Van der Maarel; Steven J Burden; Jan J Verschuuren
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.